SI-BONE

$22.06 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About SI-BONE

SI-BONE, Inc. is focused on development of medical devices. The Company is engaged in the development, manufacture and commercialization of minimally invasive surgical devices for the treatment of patients with low back symptoms related to certain sacroiliac (SI) joint disorders. The Company offers iFuse Implant System, which provides a minimally invasive surgical solution to fuse the SI joint using patented triangular titanium implants that create an interference fit within the ilium and sacrum. The triangular implant shape, combined with the press fit insertion, is designed to provide fixation by minimizing rotational motion. The implants has a porous surface that provide an environment for bone ongrowth and ingrowth, facilitating long-term fusion of the joint. The iFuse Implant System is intended for sacroiliac fusion for conditions, including sacroiliac joint dysfunction that is a direct result of sacroiliac joint disruption and degenerative sacroiliitis.

Stock Analysis

last close $22.06
1-mo return -10.1%
3-mo return -28.1%
avg daily vol. 337.51T
52-week high 37.21
52-week low 19.26
market cap. $760M
forward pe -
annual div. -
roe -34.1%
ltg forecast 40.2%
dividend yield -
annual rev. $85M
inst own. -
baraka

Subscribe now for daily local and international financial news

Subscribe